Looks like the FDA may use tougher language on the Serevent and Advair black box warnings.
At least, that’s what yesterday’s committee suggested to the FDA after considering salmeterol’s possible side effects in asthmatic children.
The current warning should address children specifically, says the independent committee, and it should warn that using the drug increases the risk […]

Filed under: Asthma Meds, Asthma News & Research, Children's Asthma, FDA Issues | 5 people talking »